Initially investigated as a cancer therapeutic due to its ability to promote apoptotic cell death specifically of tumor cells (Ziegler-Heitbrock et al. 1986), systemic TNF-α treatment has failed clinical trials as a solo cancer therapeutic due to unacceptable levels of toxicity (Roberts et al. 2011). This evidence concerns the gene TNF and cancer.